BeyondSpring Pharmaceuticals Inc.   Report issue

For profit Phase 1 Phase 3
Founded: New York NY United States (2014)

Organization Overview

First Clinical Trial
2016
NCT02504489
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

BeyondSpring Pharmaceuticals Inc.